SMNRW
SEMNUR PHARMS INC WTSstockOTC
EODNov 17, 2026 4:00:00 PM EST
0.015USD-29.245%(-0.006)51,299
SMNRW Financials
In Q3 FY 2026 (ended ), SEMNUR PHARMS INC WTS (SMNRW) reported net income of −$3.63M, operating cash flow of −$2.22M, and assets of $2.01M (filed ).
Loading financial flows…